Solas BioVentures Fund

Solas BioVentures is a venture capital firm headquartered in Chattanooga, Tennessee, that focuses exclusively on the life sciences industry. Established in 2014, the firm invests in early and development-stage companies across biopharmaceuticals, medical devices, diagnostics, and digital health. Solas BioVentures seeks out "star founders" and "breakthrough technologies" that aim to provide seismic improvements in patient outcomes. The investment team is composed of experienced clinicians, entrepreneurs, and financial experts who take an active role in supporting their portfolio. Key therapeutic areas of interest include oncology, cardiovascular health, and urology, with a portfolio featuring companies such as Areteia Therapeutics, Tvardi Therapeutics, and Francis Medical.